Nonetheless, to the best of our knowledge, this study constitutes the largest series thus far to investigate the role of VEGF changes in ESCC patients who underwent curative CCRT, and it may thus be useful for understanding the novel mechanism of the investigated disease entity. This evidence concerns the gene VEGFA and esophageal squamous cell carcinoma.